Long Chain Omega 3 Polyunsaturated Fatty Acids Supplementation in the Treatment of Elderly Depression: Effects on Depressive Symptoms, on Phospholipids Fatty Acids Profile and on Health-related Quality of Life

Overview

Journal J Nutr Health Aging

Specialties Geriatrics
Nutritional Sciences

Date 2011 Jan 27

PMID 21267525

Citations 38

Authors

M Rondanelli

A Giacosa

A Opizzi

C Pelucchi

C La Vecchia

G Montorfano

M Negroni

B Berra

P Politi

A M Rizzo

Affiliations

Soon will be listed here.

Abstract

Objective: Recent observations showed that long chain omega 3 polyunsaturated fatty acids (n-3 LCPUFA) could represent a potential treatment for elderly depression. To determine if a n-3 LCPUFA containing supplement improves depressive symptoms, changes phospholipids acids profile and ameliorates Health related quality of life (HRQoL) in depressed elderly patients.

Design: Two-months, randomized, double-blind, placebo-controlled trial.

Setting: Nursing home in Pavia, Italy.

Subjects: Forty-six depressed females, aged 66-95 years.

Intervention: 22 depressed females were included in the intervention group (n-3 group, that received 2.5 g/day of n-3 LCPUFA, with 1.67 grams of EPA and 0.83 grams of DHA), and 24 patients in the placebo group. The primary endpoint was the improvement of depressive symptoms as evaluated by Geriatric Depression Scale (GDS). Secondary endpoints were the evaluation of modifications of erythrocyte membrane phospholipids fatty acid profile and of of HRQoL, by using the Short-Form 36-Item Health Survey (SF-36). All parameters were assessed before and after the treatment period of 8 weeks.

Results: The mean GDS at 2 months was significantly lowered only for the n-3 group. SF-36 physical and mental components were significantly increased in the intervention group. Compliance was good, as confirmed by erythrocyte membrane phospholipid FA concentrations, with significant increase of EPA and DHA in the intervention group.

Conclusion: The supplementation of n-3 LCPUFA in elderly female patients reduces the occurrence of depressive symptoms, improves phospholipids fatty acids profile and health-related quality of life.

Citing Articles

Omega-3 Fatty Acids and Neuroinflammation in Depression: Targeting Damage-Associated Molecular Patterns and Neural Biomarkers.

Malau I, Chang J, Lin Y, Chang C, Chiu W, Su K Cells. 2024; 13(21.

PMID: 39513898 PMC: 11544853. DOI: 10.3390/cells13211791.

A scoping review of over-the-counter products for depression, anxiety and insomnia in older people.

Frost R, Mathew S, Thomas V, Uddin S, Salame A, Vial C BMC Complement Med Ther. 2024; 24(1):275.

PMID: 39033116 PMC: 11264918. DOI: 10.1186/s12906-024-04585-0.

Omega-3 Fatty Acids, Cognition, and Brain Volume in Older Adults.

Loong S, Barnes S, Gatto N, Chowdhury S, Lee G Brain Sci. 2023; 13(9).

PMID: 37759879 PMC: 10526215. DOI: 10.3390/brainsci13091278.

The Therapeutic Impact of Plant-Based and Nutritional Supplements on Anxiety, Depressive Symptoms and Sleep Quality among Adults and Elderly: A Systematic Review of the Literature.

Kamat D, Al-Ajlouni Y, Hall R Int J Environ Res Public Health. 2023; 20(6).

PMID: 36982079 PMC: 10049309. DOI: 10.3390/ijerph20065171.

Anti-Inflammatory Treatment Efficacy in Major Depressive Disorder: A Systematic Review of Meta-Analyses.

Simon M, Arteaga-Henriquez G, Algendy A, Siepmann T, Illigens B Neuropsychiatr Dis Treat. 2023; 19:1-25.

PMID: 36636142 PMC: 9830720. DOI: 10.2147/NDT.S385117.

References

Pearson J, Brown G . Suicide prevention in late life: directions for science and practice. Clin Psychol Rev. 2000; 20(6):685-705. DOI: 10.1016/s0272-7358(99)00066-5. View

Hibbeln J . Fish consumption and major depression. Lancet. 1998; 351(9110):1213. DOI: 10.1016/S0140-6736(05)79168-6. View

Zimmer L, Vancassel S, Cantagrel S, Breton P, Delamanche S, Guilloteau D . The dopamine mesocorticolimbic pathway is affected by deficiency in n-3 polyunsaturated fatty acids. Am J Clin Nutr. 2002; 75(4):662-7. DOI: 10.1093/ajcn/75.4.662. View

Hallaq H, Smith T, Leaf A . Modulation of dihydropyridine-sensitive calcium channels in heart cells by fish oil fatty acids. Proc Natl Acad Sci U S A. 1992; 89(5):1760-4. PMC: 48532. DOI: 10.1073/pnas.89.5.1760. View

Yesavage J, Brink T, Rose T, Lum O, Huang V, Adey M . Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982; 17(1):37-49. DOI: 10.1016/0022-3956(82)90033-4. View

Stahl L, Begg D, Weisinger R, Sinclair A . The role of omega-3 fatty acids in mood disorders. Curr Opin Investig Drugs. 2008; 9(1):57-64. View

Hakkarainen R, Partonen T, Haukka J, Virtamo J, Albanes D, Lonnqvist J . Is low dietary intake of omega-3 fatty acids associated with depression?. Am J Psychiatry. 2004; 161(3):567-9. DOI: 10.1176/appi.ajp.161.3.567. View

Delion S, Chalon S, Herault J, Guilloteau D, Besnard J, Durand G . Chronic dietary alpha-linolenic acid deficiency alters dopaminergic and serotoninergic neurotransmission in rats. J Nutr. 1994; 124(12):2466-76. DOI: 10.1093/jn/124.12.466. View

Luber M, Meyers B, Hollenberg J, DiDomenico T, Charlson M, Alexopoulos G . Depression and service utilization in elderly primary care patients. Am J Geriatr Psychiatry. 2001; 9(2):169-76. View

10.

Chalon S, Vancassel S, Zimmer L, Guilloteau D, Durand G . Polyunsaturated fatty acids and cerebral function: focus on monoaminergic neurotransmission. Lipids. 2001; 36(9):937-44. DOI: 10.1007/s11745-001-0804-7. View

11.

Parker G, Gibson N, Brotchie H, Heruc G, Rees A, Hadzi-Pavlovic D . Omega-3 fatty acids and mood disorders. Am J Psychiatry. 2006; 163(6):969-78. DOI: 10.1176/ajp.2006.163.6.969. View

12.

Folstein M, Folstein S, McHugh P . "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12(3):189-98. DOI: 10.1016/0022-3956(75)90026-6. View

13.

Marangell L, Martinez J, Zboyan H, Kertz B, Kim H, Puryear L . A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am J Psychiatry. 2003; 160(5):996-8. DOI: 10.1176/appi.ajp.160.5.996. View

14.

Gallo J, Lebowitz B . The epidemiology of common late-life mental disorders in the community: themes for the new century. Psychiatr Serv. 1999; 50(9):1158-66. DOI: 10.1176/ps.50.9.1158. View

15.

Owen C, Rees A, Parker G . The role of fatty acids in the development and treatment of mood disorders. Curr Opin Psychiatry. 2008; 21(1):19-24. DOI: 10.1097/YCO.0b013e3282f29841. View

16.

Carroll D, Roth M . Evidence for the cardioprotective effects of omega-3 Fatty acids. Ann Pharmacother. 2002; 36(12):1950-6. DOI: 10.1345/aph.1A314. View

17.

Zimmer L, Hembert S, Durand G, Breton P, Guilloteau D, Besnard J . Chronic n-3 polyunsaturated fatty acid diet-deficiency acts on dopamine metabolism in the rat frontal cortex: a microdialysis study. Neurosci Lett. 1998; 240(3):177-81. DOI: 10.1016/s0304-3940(97)00938-5. View

18.

Innis S, Kuhnlein H, Kinloch D . The composition of red cell membrane phospholipids in Canadian Inuit consuming a diet high in marine mammals. Lipids. 1988; 23(11):1064-8. DOI: 10.1007/BF02535653. View

19.

Peet M . Eicosapentaenoic acid in the treatment of schizophrenia and depression: rationale and preliminary double-blind clinical trial results. Prostaglandins Leukot Essent Fatty Acids. 2003; 69(6):477-85. DOI: 10.1016/j.plefa.2003.08.020. View

20.

Simopoulos A . Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed Pharmacother. 2006; 60(9):502-7. DOI: 10.1016/j.biopha.2006.07.080. View